Has Samantha Clifford received payments from drug or device companies?

Yes. Drug and device makers reported $3,628 in general payments to Samantha Clifford across 222 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Samantha Clifford did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Samantha Clifford come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Samantha Clifford

Psychiatric/Mental Health · Louisville, KYNPI 1881116929

Payments from drug & device makers

$3,628in general payments, 2019–2025

Across 222 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bausch Health US, LLC$917
AbbVie$511
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$319
Otsuka America Pharmaceutical, Inc.$236
Lundbeck LLC$228
Vanda Pharmaceuticals Inc.$172
plus $1K from 18 others

What the payments were for

Food & beverage$3,58299%
Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bausch Health US, LLC	72	$917
AbbVie	40	$511
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	13	$319
Otsuka America Pharmaceutical, Inc.	11	$236
Lundbeck LLC	11	$228
Vanda Pharmaceuticals Inc.	7	$172
Noven Therapeutics, LLC	9	$163
Corium, LLC	9	$140
Tris Pharma Inc	8	$140
Alkermes, Inc.	6	$139
Teva Pharmaceuticals USA, Inc.	8	$133
Johnson & Johnson	5	$92
Takeda Pharmaceuticals U.S.A., Inc.	4	$74
Ironshore Pharmaceuticals Inc.	3	$69
Almatica Pharma LLC	3	$67
Axsome Therapeutics, Inc.	3	$65
Sunovion Pharmaceuticals Inc.	2	$35
Idorsia Pharmaceuticals US Inc	2	$27
Neos Therapeutics, LP	1	$19
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$19
Aytu Biopharma, Inc.	1	$18
Collegium Pharmaceutical, Inc.	1	$18
Adlon Therapeutics L.p.	1	$14
Supernus Pharmaceuticals, Inc.	1	$14

How this compares

$3,628 in reported general payments places this provider in the 85th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	31	$1,328
Quetiapine Fumarate	33	$809
Aripiprazole	13	$679
Naltrexone Hcl	11	$643
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	27	$469
Bupropion Hcl SrBupropion Hcl	19	$326
Bupropion XlBupropion Hcl	33	$310
Lamotrigine	53	$282
Olanzapine	18	$227
Amitriptyline Hcl	11	$224
Fluoxetine Hcl	16	$213
Lorazepam	37	$192
Diazepam	28	$186
Clonazepam	47	$140
Tizanidine Hcl	11	$103

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Louisville

Denise de AngelisLouisville$384K
Mark BushLouisville$52K
Harold O'BrienLouisville$28K
Shane WattsLouisville$13K
Clinton RayhillLouisville$9K
Michelle LoseLouisville$7K
Ryan HopsonLouisville$7K
Kimberly ViltLouisville$7K
Theresa WattsAshland$645K
Rachel ColeHopkinsville$503K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →